John L. Peterson – författare

Public health has a legacy of neglect regarding social and behavioral research. Too often, prompted by technical and scientific progress, we have ignored­ even marginalized-the vital "human element" in health thinking and prac­ tice. Thus, for example, while family planning programs focused on providing a choice among safe and effective contraceptive methods (a supremely worthy goal), the central issue of sexuality and sexual behavior was generally neglected. Similarly, the enormous and important efforts to develop rapid and reliable diagnostic and treatment methods for sexually transmitted diseases helped divert attention away from the crucial issues of sexual practice. In short, we seem to have difficulty addressing the fundamental behaviors-including sex, drug taking and other intoxications, and violence-that are central to the major causes of preventable morbidity, disability, and premature mortality in the world today. Our collective reluctance to examine and understand ourselves is also expressed in the oft-repeated pipedream that scientific progress will "take care of" the HIV / AIDS pandemic by delivering a preventive vaccine, an effective cure, or both. Yet even a cursory glance at the relationship between scientific/ technical progress and health shows that meeting the scientific challenges is only one step toward effective application of the vaccine or drug. It is typical, not atypical, that hepatitis B vaccine is only now becoming relatively freely available to large populations in the developing world, more than a decade after the vaccine's licensure.

This handbook is intended to provide a comprehensive overview of the theories, methods and approaches for reducing HIV-associated risk behaviours. The handbook addresses the subject of HIV prevention from two interrelated perspectives. First, it presents the seminal theories currently used to guide the development and implementation of HIV prevention interventions. Second, it describes prevention approaches for diverse populations at risk of HIV infection. This handbook provides a compilation of knowledge on HIV prevention by the leading authorities in the field, and should be an important resource for students, researchers and clinicians in the field.

In the nearly two decades since the HIV pandemic began, the rapid expansion of behavioral research on HIV prevention has prompted a crucial need for a sourcebook more advanced than an introductory textbook and broader and more readily accessible than a review periodical. The Handbook of HIV Prevention is intended as the first attempt to meet this need. The current state of affairs led us to edit a book that would represent the major areas of HIV behavioral research at a level appropriate for graduate students and experienced researchers in public health, medicine, nursing, education, and the social and behavioral sciences. In addition, we expect that the handbook will be useful in advanced undergraduate courses and as a reference book for health care professionals. Our plans to assemble the Handbook began in the fall of 1996 when we prepared a tentative outline of chapters and invited a large number of distinguished researchers in the field to be the authors of various chapters. We received an overwhelmingly favorable response from potential authors to our letters of invitation. After considerable effort by both the contributors and the editors the volume was completed in 1999, when all chapters went to press.

In the nearly two decades since the HIV pandemic began, the rapid expansion of behavioral research on HIV prevention has prompted a crucial need for a sourcebook more advanced than an introductory textbook and broader and more readily accessible than a review periodical. The Handbook of HIV Prevention is intended as the first attempt to meet this need. The current state of affairs led us to edit a book that would represent the major areas of HIV behavioral research at a level appropriate for graduate students and experienced researchers in public health, medicine, nursing, education, and the social and behavioral sciences. In addition, we expect that the handbook will be useful in advanced undergraduate courses and as a reference book for health care professionals. Our plans to assemble the Handbook began in the fall of 1996 when we prepared a tentative outline of chapters and invited a large number of distinguished researchers in the field to be the authors of various chapters. We received an overwhelmingly favorable response from potential authors to our letters of invitation. After considerable effort by both the contributors and the editors the volume was completed in 1999, when all chapters went to press.

Public health has a legacy of neglect regarding social and behavioral research. Too often, prompted by technical and scientific progress, we have ignored­ even marginalized-the vital "human element" in health thinking and prac­ tice. Thus, for example, while family planning programs focused on providing a choice among safe and effective contraceptive methods (a supremely worthy goal), the central issue of sexuality and sexual behavior was generally neglected. Similarly, the enormous and important efforts to develop rapid and reliable diagnostic and treatment methods for sexually transmitted diseases helped divert attention away from the crucial issues of sexual practice. In short, we seem to have difficulty addressing the fundamental behaviors-including sex, drug taking and other intoxications, and violence-that are central to the major causes of preventable morbidity, disability, and premature mortality in the world today. Our collective reluctance to examine and understand ourselves is also expressed in the oft-repeated pipedream that scientific progress will "take care of" the HIV / AIDS pandemic by delivering a preventive vaccine, an effective cure, or both. Yet even a cursory glance at the relationship between scientific/ technical progress and health shows that meeting the scientific challenges is only one step toward effective application of the vaccine or drug. It is typical, not atypical, that hepatitis B vaccine is only now becoming relatively freely available to large populations in the developing world, more than a decade after the vaccine''s licensure.